Penumbra, Inc Payments of Merger Related Costs, Financing Activities
Penumbra, Inc (PEN) reported Payments of Merger Related Costs, Financing Activities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2023-02-23
- Penumbra, Inc payments of merger related costs, financing activities for the quarter ending 2019-03-31 was $683.00K, a 84.20% decline year-over-year.
- Penumbra, Inc payments of merger related costs, financing activities for the quarter ending 2018-12-31 was $50.00K.
- Penumbra, Inc payments of merger related costs, financing activities for the quarter ending 2018-09-30 was $0.00.
- Penumbra, Inc payments of merger related costs, financing activities for the quarter ending 2018-06-30 was $108.00K.
- Penumbra, Inc payments of merger related costs, financing activities for fiscal 2022 was $0.00.
- Penumbra, Inc payments of merger related costs, financing activities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Penumbra, Inc payments of merger related costs, financing activities for fiscal 2020 was $683.00K, a 61.15% decline from fiscal 2019.
- Penumbra, Inc payments of merger related costs, financing activities for fiscal 2019 was $1.76M, a 60.77% decline from fiscal 2018.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 9 month | Payments of Merger Related Costs, Financing Activities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $683.00K 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $1.76M 10-K · filed 2022-02-22 | |||
| 2019-03-31 | $683.00K 10-Q · filed 2019-05-07 | $733.00K derived: sum of 2 quarters · filed 2021-02-23 | $733.00K derived: sum of 3 quarters · filed 2021-02-23 | $841.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $50.00K derived: sum of 2 quarters · filed 2021-02-23 | $158.00K derived: sum of 3 quarters · filed 2021-02-23 | $4.48M 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $108.00K derived: sum of 2 quarters · filed 2018-11-05 | $4.43M 10-Q · filed 2018-11-05 | $4.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $4.43M 10-Q · filed 2018-08-07 | $4.43M derived: sum of 3 quarters · filed 2020-02-26 | $4.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $4.32M 10-Q · filed 2019-05-07 | $4.32M derived: sum of 2 quarters · filed 2020-02-26 | $4.32M derived: sum of 3 quarters · filed 2020-02-26 | $4.32M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $0.00 derived: sum of 2 quarters · filed 2020-02-26 | $0.00 derived: sum of 3 quarters · filed 2020-02-26 | $0.00 10-K · filed 2020-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |